Walleye Capital’s Altimmune ALT Stock Holding History

Walleye Capital’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41K	Buy	13,500 +2,700	+25%	+$8.06K	﹤0.01%	4244
2026 Q1	$33.3K	Sell	10,800 -53,600	-83%	-$228K	﹤0.01%	3988
2025 Q4	$232K	Sell	64,400 -24,000	-27%	-$105K	﹤0.01%	3466
2025 Q3	$333K	Buy	88,400 +65,000	+278%	+$251K	﹤0.01%	2926
2025 Q2	$90.6K	Buy	+23,400	New	+$127K	﹤0.01%	3820
2025 Q1	–	Sell	-13,600	Closed	-$98.1K	–	4192
2024 Q4	$98.1K	Buy	+13,600	New	+$104K	﹤0.01%	4153
2024 Q3	–	Sell	-11,400	Closed	-$75.8K	–	5219
2024 Q2	$75.8K	Buy	11,400 +7,900	+226%	+$58.3K	﹤0.01%	4818
2024 Q1	$35.6K	Buy	+3,500	New	+$35.6K	﹤0.01%	4780
2023 Q2	–	Sell	-200	Closed	-$844	–	4265
2023 Q1	$844	Buy	+200	New	+$2.38K	﹤0.01%	3835
2022 Q4	–	Sell	-15,700	Closed	-$200K	–	3145
2022 Q3	$200K	Buy	+15,700	New	+$232K	﹤0.01%	2119

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's ALT Position: Q2 2026 in Review

Walleye Capital increased its Altimmune (ALT) stake by 424,850% in Q2 2026, buying an estimated $25.4K and bringing the position to 8,499 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

Walleye Capital first reported a position in ALT in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.58M in Q2 2022. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Walleye Capital held 8,499 shares of Altimmune worth $25.8K as of Q2 2026.
Walleye Capital bought 8,497 Altimmune shares in Q2 2026, an estimated $25.4K.
Altimmune made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4343 holding.
Walleye Capital first reported a position in Altimmune in Q4 2021 and has held it in 13 quarters since.
Walleye Capital's Altimmune position peaked at $1.58M in Q2 2022.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.